Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Unimedic Pharma AB
AB
Active
Org 5565579967
Sundbybergsvägen 1, 171 73
Solna
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1998 · 27 years old
32 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Unimedic Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
110M
219M
329M
438M
248M
2021
316M
2022
381M
2023
335M
2024
301M
2025
EBITDA
SEK millions
104M
78M
52M
26M
0M
38M
2021
77M
+103%
2022
83M
+8%
2023
35M
-58%
2024
11M
-69%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
248 248
315 501
381 109
335 088
300 823
Staff expenses
—
—
—
—
—
EBITDA
37 533
76 665
82 828
35 109
11 231
Depreciation & amort.
−6 587
−7 354
−7 385
−5 623
−3 922
EBIT
30 946
69 311
75 443
29 486
7 309
Net financials
−772
−2 215
−3 212
−4 194
−3 897
Profit before tax
6 912
21 055
48 946
23 099
−132
Tax
−1 408
−4 402
−10 129
−4 800
−811
Net profit
5 504
16 653
38 817
18 299
−943
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
136 559
198 791
199 418
197 188
501 494
Equity
20 218
36 870
75 687
93 986
93 043
Long-term debt
55 518
76 901
66 226
66 820
283 664
Short-term debt
60 823
85 020
57 505
36 382
124 787
Total debt
116 341
161 921
123 731
103 202
408 451
Financial ratios
5-year trend
EBITDA margin
3.7%
This company
15.8%
Market median
-77% vs market
2021
2025
Equity ratio
18.6%
This company
38.2%
Market median
-51% vs market
2021
2025
Return on equity
-1.0%
This company
18.4%
Market median
-105% vs market
2021
2025
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
2021
2025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
2021
2025
Debt / equity
4.39×
This company
0.62×
Market median
-608% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Unimedic Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
